Xenon's High Stakes Gamble on Epilepsy Care: Can a New Player Shake Up an Old Market?
The European Epilepsy Congress is set to host data presentations from Xenon Pharmaceuticals, a clinical stage biotech building momentum in epilepsy research.
The company's efforts are not without risk – they embody the trend of pursuing novel mechanisms of action at any cost.